Alimera Sciences Closes $30 Million in Series C Financing, Increasing Stake in Medidur(TM) FA
...acquire a majority stake in Medidur(TM) FA, the company's Phase
III investigative treatment for diabetic macular edema (DME), from
development partner psivida
Ltd (Nasdaq: PSDV , ASX: PSD, Xetra: PSI) and
fund the remaining development obligations for the product.
Under the new agreement, Alimera will ass...
DSMB Supports Continuation of the Phase 3 Clinical Trial of Medidur(TM) FA for the Treatment of DME
recruitment phase of this pivotal study," said psivida
Director, Dr. Paul Ashton. Curre...ease visit
http://www.alimerasciences.com About psivida
Limited pSivida, a Boston, MA. based global drug ...)
technology which underpins the Medidur product. psivida
owns the rights to develop and commercialize a mod...
PSivida, Pfizer Ink $165 Million Licensing Pact
... Perth-based bio-nanotech major, psivida
Limited has signed an exclusive worldwide Collabor...lications.
Under the terms of the agreement, psivida
will receive up to $155 million in development and...laboration in ophthalmic applications and will pay psivida
a royalty on net sales of those products.
PSivida in Medical Technology
Enrollment Complete in Pivotal Phase 3 Trial of Medidur(TM) FA for Diabetic Macular Edema
ophthalmic pharmaceutical company, and psivida
Limited (Nasdaq: PSDV; ASX:
PSD; Xetra: PSI), anno...ficacy assessed at two years. Alimera Sciences and psivida
jointly developing Medidur FA under a collabor...ease visit http://www.alimerasciences.com About psivida
Enrollment Begins on Human PK Study for Medidur(TM) FA
...vately held ophthalmic pharmaceutical company, and psivida
(Nasdaq: PSDV , ASX: PSD, Xetra: PSI) tod...ls in the anterior
chamber." Alimera Sciences and psivida
Limited have a worldwide agreement to
co-develop a...r," said Dr
Paul Ashton, PhD, Managing Director of psivida
Limited. "Additionally, by
determining anterior ch...
PSivida in Biological Technology